Patents by Inventor Nathalie Borie

Nathalie Borie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF ASSESSING A PROPENSITY OF CLINICAL OUTCOME FOR A FEMALE MAMMAL SUFFERING FROM BREAST CANCER
    Publication number: 20100234292
    Abstract: The present invention relates to a method of assessing a propensity of clinical outcome for a female mammal suffering from breast cancer in view of the expression of specific nucleic acid sequences in a biological sample.
    Type: Application
    Filed: April 16, 2008
    Publication date: September 16, 2010
    Applicants: IPSOGEN, INSERM - INSTITUT NATIONAL DE LA SANTE ET DE LA RE CHECHE MEDICALE, INSTITUT PAOLI-CALMETTES
    Inventors: Francois Bertucci, Daniel Birnbaum, Patrice Viens, Vincent Fert, Fabienne Hermitte, Stephane Debono, Stephane Deraco, Nathalie Borie, Fanny Piette
  • IDENTIFICATION OF AN ERBB2 GENE EXPRESSION SIGNATURE IN BREAST CANCERS
    Publication number: 20090092983
    Abstract: A method for analyzing differential gene expression associated with breast tumor is based on the analysis of the over-expression or under-expression of polynucleotide sequences in a biological sample. The analysis includes the detection of the over-expression of at least one polynucleotide sequence(s), subsequence(s) or complement(s) thereof selected from predefined polynucleotide sequence sets.
    Type: Application
    Filed: September 17, 2008
    Publication date: April 9, 2009
    Inventors: Daniel Birnbaum, Francois Bertucci, Jocelyne Jacquemier, Stephane Debono, Nathalie Borie, Christophe Ginestier
  • Identification of an ERBB2 gene expression signature in breast cancers
    Publication number: 20050089899
    Abstract: The present invention relates to a method for analyzing differential gene expression associated with breast tumor, based on the analysis of the over-expression or under-expression of polynucleotide sequences in a biological sample. The analysis comprises the detection of the over-expression of at least one polynucleotide sequence(s), subsequence(s) or complement(s) thereof selected from predefined polynucleotide sequence sets.
    Type: Application
    Filed: August 27, 2004
    Publication date: April 28, 2005
    Inventors: Daniel Birnbaum, Francois Bertucci, Jocelyne Jacquemier, Stephane Debono, Nathalie Borie, Christophe Ginestier